Response to the letter to the editor: ‘Olezarsen, a liver-directed APOC3 ASO therapy for hypertriglyceridemia’

Research output: Contribution to journalLetterpeer-review

Original languageEnglish
Pages (from-to)111-112
Number of pages2
JournalExpert Opinion on Pharmacotherapy
Volume26
Issue number1
Early online date8 Dec 2024
DOIs
Publication statusPublished - 2025

Cite this